Early in 2024, we reported on the FDA's call for new boxed warnings on the labeling of all approved chimeric antigen receptor ...

Patients with liver tumors that meet the following may be candidates: The tumor is less than 4 centimeters in size Have three or fewer tumors The tumor is in a favorable location for treatment Talk to ...

KT-333 is under clinical development by Kymera Therapeutics and currently in Phase I for Unspecified B-Cell Lymphomas. According to GlobalData, Phase I drugs for Unspecified B-Cell Lymphomas does not ...

Linperlisib is under clinical development by Shanghai Yingli Pharmaceutical and currently in Phase I for Hematological Tumor.

There, a multidisciplinary team assembled to get Bridget back on the field. Spinal cord tumors are also classified by cell type. A pathologist will examine the cells microscopically and assign a grade ...

The regulator has also mandated the disclosure of granular details of all entities that hold ownership, economic interest or control in ODIs. This is applicable to ODI subscribers who have ...

Atypical teratoid rhabdoid tumors (AT/RT) were treated with “carboplatin + pirarubicin + cyclophosphamide” or “ifosfamide + carboplatin + etoposide”. Germinomas were typically treated with ...

We work right across the cancer research pathway with strengths ranging from cell biology to healthcare research. We aim to nurture the thought leaders of today and tomorrow through the provision of ...

The single-cell analysis revealed a diverse range of cell types within the tumor microenvironment (TME), including tumor cells, immune cells, and fibroblasts, with varying proportions across cases.